1: Miranda C, Zanotti G, Pagliardini S, Ponzetto C, Pierotti MA, Greco A. Related Articles, Links
Gain of function mutations of RTK conserved residues display differential effects on NTRK1 kinase activity.
Oncogene. 2002 Nov 28;21(54):8334-9.
PMID: 12447696 [PubMed - indexed for MEDLINE]
2: Rodriguez GJ, Balsalobre MD, Pomares F, Torregrosa NM, Rios A, Carbonell P, Glower G, Sola J, Tebar J, Parrilla P. Related Articles, Links
Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center.
J Am Coll Surg. 2002 Aug;195(2):159-66.
PMID: 12168961 [PubMed - indexed for MEDLINE]
3: Gil L, Azanedo M, Pollan M, Cristobal E, Arribas B, Garcia-Albert L, Garcia-Saiz A, Maestro ML, Torres A, Menarguez J, Rojas JM. Related Articles, Links
Genetic analysis of RET, GFR alpha 1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A.
Int J Cancer. 2002 May 10;99(2):299-304.
PMID: 11979448 [PubMed - indexed for MEDLINE]
4: Longati P, Comoglio PM, Bardelli A. Related Articles, Links
Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene.
Curr Drug Targets. 2001 Mar;2(1):41-55. Review.
PMID: 11465538 [PubMed - indexed for MEDLINE]
5: Mai KT, Landry DC, Thomas J, Burns BF, Commons AS, Yazdi HM, Odell PF. Related Articles, Links
Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.
Histopathology. 2001 Jul;39(1):25-32.
PMID: 11454041 [PubMed - indexed for MEDLINE]
Time used: 47 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005